This research develops antibacterial nanostructured surfaces inspired by natural materials such as cicada wings. The engineered surfaces physically rupture bacteria using nanoscale needle-like structures, avoiding traditional antibiotics and reducing the likelihood of antibiotic resistance. The technology could improve infection control in medical devices, implants, and hospital environments.

This talk traces the devastation of the Black Death to highlight a modern crisis: antibiotic resistance. Misuse of antibiotics accelerates the rise of superbugs. Using AI and machine learning, the research identifies genetic resistance patterns and guides effective treatments, aiming to improve clinical decisions and prevent a return to a pre-antibiotic era.

This research examines how microorganisms in maple sap influence the quality of maple syrup. By studying bacteria such as Pseudomonas and Duganella, the project explores how environmental factors like temperature and iron availability shape microbial interactions during the tapping season, ultimately affecting syrup flavor, color, and overall production.

This research investigates how a gonorrhea protein is processed in E. coli using cellular signal sequences, which act like "ZIP codes" directing the protein to its proper location. By identifying effective signal sequences, the study informs potential molecular targets for earlier detection and better treatment, aiming to prevent gonorrhea-related infertility and improve women's reproductive health.

 

This research investigates how bacteria develop resistance to antibiotics, a growing global health threat. By identifying resistant bacteria and analysing how they chemically modify antibiotics, the work aims to uncover resistance mechanisms. These insights are essential for preserving antibiotic effectiveness and safeguarding treatments against life-threatening infections.

This research tackles antibiotic resistance by developing nano-scale microfluidic cultures that isolate and study previously unculturable bacteria. By screening rare microbes and directly testing their antimicrobial activity, the platform accelerates discovery of new antibiotics, offering a powerful tool against drug-resistant superbugs.